Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.20
-0.2800-2.08%
Post-market: 13.200.00000.00%19:30 EDT
Volume:180.68K
Turnover:2.39M
Market Cap:225.79M
PE:-3.42
High:13.59
Open:13.53
Low:12.96
Close:13.48
52wk High:16.77
52wk Low:11.13
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.84
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:1.05
PE(LYR):-4.14

Loading ...

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Dow Jones
·
Apr 28

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload

GlobeNewswire
·
Apr 27

Press Release: TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University

Dow Jones
·
Apr 27

BUZZ-U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks

Reuters
·
Apr 24

Atrium Therapeutics earns $15 million milestone payment from Bristol Myers Squibb

Reuters
·
Apr 23

Atrium Therapeutics Inc - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS
·
Apr 23

Atrium Therapeutics Earns $15 Million Milestone Payment From Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS
·
Apr 23

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Clinical, Regulatory, Commercialization Activities From Collaboration

THOMSON REUTERS
·
Apr 23

Perth biotech at cutting edge of the future of medicine

The West Australian
·
Apr 23

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

GlobeNewswire
·
Apr 22

Atrium Therapeutics grants inducement equity awards to seven new hires under Nasdaq rule

Reuters
·
Apr 21

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 21

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

GlobeNewswire
·
Apr 16

Circio clears 2025 reports as funding extends RNA platform runway to 2030

TIPRANKS
·
Apr 16

Circio adjusts equity incentives to offset dilution from NOK 50 million rights issue

TIPRANKS
·
Apr 16

Microbix Showcases Novel RNA Assay Controls at ESCMID Global 2026

TIPRANKS
·
Apr 15

Circio Finalizes Capital Increase to Fund Circular RNA Platform Growth

TIPRANKS
·
Apr 14

ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event

GlobeNewswire
·
Apr 09

ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board

GlobeNewswire
·
Apr 08

Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing

GlobeNewswire
·
Apr 06